Cor Vasa 2023, 65(3):501-507 | DOI: 10.33678/cor.2022.132

The relationship between the level of soluble CD40 ligand and angiographic extent and severity of coronary artery disease

Betül Cengiz Elçioğlua, Şükrü Taylan Şahinb, Evin Bozçalic, Şölen Himmetoğlud, Hüsniye Yüksele
a Department of Cardiology, Koç University Hospital, Istanbul, Turkey
b Department of Cardiology, Istanbul American Hospital, Istanbul, Turkey
c Department of Cardiology, Okmeydani Training and Research Hospital, Istanbul, Turkey
d Department of Biochemistry, TC Biruni University Medical Faculty, Istanbul, Turkey
e Department of Cardiology, Istanbul University Cerrahpaşa Medical Faculty, Istanbul, Turkey

Objectives: Previous studies have suggested that atherosclerosis is a chronic inflammatory disease and implicate components of the immune system in atherogenesis. The CD40 and CD40 ligand system regulates multiple phases of the humoral and cellular immune response. Soluble CD40 (sCD40) ligand especially releases from activated platelets. Platelets are involved not only in thrombosis, but also in atherosclerotic lesion formation and restenosis processes. The aim of our study is to evaluate whether there is a relationship between the level of sCD40 ligand and angiographic extent and severity of coronary artery disease (CAD) and to compare other cardiovascular risk factors.

Methods: 102 participants were included in our study. Among them, 37 patients constituted acute coronary syndrome (ACS) group, 41 patients were diagnosed as stable angina pectoris group (SAP), while 24 subjects served as control group. Peripheral venous blood samples were drawn at the Coronary Care Unit admission of ACS group patients. From SAP group patients and controls who have normal coronary arteries, blood samples collected after coronary angiography. The Gensini score was computed for each patient by assigning the severity score to each coronary stenosis in accordance with the degree of the vessel narrowing and its geographic importance.

Keywords: Coronary artery disease, Gensini score, Soluble CD40 ligand

Received: October 26, 2022; Revised: October 26, 2022; Accepted: December 18, 2022; Published: June 20, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Elçioğlu BC, Taylan Şahin Ş, Bozçali E, Himmetoğlu Ş, Yüksel H. The relationship between the level of soluble CD40 ligand and angiographic extent and severity of coronary artery disease. Cor Vasa. 2023;65(3):501-507. doi: 10.33678/cor.2022.132.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Bentzon JF, Otsuka F, Virmani R, et al. Mechanisms of plaque formation and rupture. Circ Res 2014;114:1852-1866. Go to original source...
    2. Ross R. Atherosclerosis and inflamatory disease. N Engl J Med 1999;340:115-126. Go to original source...
    3. Ridker PM, Buring JE, Cook NR, et al. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14719 initially healthy American women. Circulation 2003;107:391-397. Go to original source...
    4. Ridker PM, Rifai N, Stamper MJ, et al. Plasma concentration of IL-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000;101:1767-1772. Go to original source...
    5. Ridker PM, Buring JE, Rifai N. Soluble P-selectin and the risk of future cardiovascular events. Circulation 2001;103:491-495. Go to original source...
    6. Schönbeck U, Libby P. The CD40/CD154 receptor/ligand dyad. Cell Mol Life Sci 2001;58:4-43. Go to original source... Go to PubMed...
    7. Mach F, Schonbeck U, Sukhova GK, et al. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages:implication for CD40-CD40 ligand signaling in atherosclerosis. Proc Natl Acad Sci USA 1997;94:1931-1936. Go to original source... Go to PubMed...
    8. de Lemos JA, Zirlik A, Schönbeck U, et al. Associations between soluble CD40 ligand, atherosclerosis risk factors, and subclinical atherosclerosis: results from the Dallas Heart Study.
    9. Arterioscler Thromb Vasc Biol 2005;25:2192-2196. Go to original source...
    10. Yao Y, Li X, Ji Q, et al. Interaction of Lipids, Mean Platelet Volume, and the Severity of Coronary Artery Disease Among Chinese Adults: A Mediation Analysis. Front Cardiovasc Med 2022;9:753171. Go to original source... Go to PubMed...
    11. Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983;51:606. Go to original source...
    12. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002;105:1135-1143 Go to original source...
    13. Wang L, Tang C. Targeting Platelet in Atherosclerosis Plaque Formation: Current Knowledge and Future Perspectives. Int J Mol Sci 2020;21:9760. Go to original source...
    14. Heeschen C, Dimmeler S, Hamm CW, et al.; CAPTURE Study Investigators. Soluble CD40 ligand in acute coronary syndromes. N Engl J Med 2003;348:1104-1111. Go to original source...
    15. Garlichs CD, Eskafi S, Raaz D, et al. Patients with acute coronary syndromes express enhanced CD40 ligand/CD154 on platelets. Heart 2001;86:649-655. Go to original source... Go to PubMed...
    16. Setianto BY, Hartopo AB, Achadiono DN, et al. Association between levels of circulating soluble CD40 ligand on admission and in-hospital events among acute coronary syndrome patients. Acta Med Indones 2011;43:82-87. Go to PubMed...
    17. Zhao W, Zhang F, Li Z, et al. Soluble CD40 ligand is associated with angiographic severity of coronary artery disease in
    18. Ekici B, Erkan AF, Alhan A, et al. Is mean platelet volume associated with the angiographic severity of coronary artery disease? Kardiol Pol 2013;71:832-838. Go to original source... Go to PubMed...
    19. patients with acute coronary syndrome. Chin Med J (Engl) 2014;127:2218-2221. Go to PubMed...
    20. Shah PK. Mechanisms of plaque vulnerability and rupture. J Am Coll Cardiol 2003;41(4 Suppl S):15S-22S. Go to original source...
    21. Mozaffarian D, Benjamin EJ, Go AS, et al; on behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. AHA statistical update. Heart disease and stroke statistics - 2016 update: a report from the American Heart Association. Circulation 2016;133:e38-e360.
    22. Moreno PR. Vulnerable Plaque: Definition, Diagnosis, and Treatment. Cardiology Clinics 2010;28:1-30. Go to original source... Go to PubMed...
    23. Virmani R, Kolodgie FD, Burke AP, et al. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000;20:1262-1275. Go to original source...
    24. Michelson AD, Barnard MR, Kruger LA, et al. Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin. Studies in baboons, human coronary intervention, and human acute myocardial infarction. Circulation 2001;104:1533-1537. Go to original source...

    This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.


    Return to the content


    Cor et Vasa

    You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

    I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.


    No
    Yes